Replies to post #3700 on Ariad Pharmaceuticals Inc fka ARIA

[BTH]

ODAC rejected a label expansion to a MRK drug

OK, Merck's drug FAILED to get approved for a label-expansion which would add substantial revenues to the company's ongoing operations.

Drug FAILED to get label expansion - that's good enough for me.